vs
Side-by-side financial comparison of DYNAVAX TECHNOLOGIES CORP (DVAX) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.
PARK NATIONAL CORP is the larger business by last-quarter revenue ($168.3M vs $94.9M, roughly 1.8× DYNAVAX TECHNOLOGIES CORP). DYNAVAX TECHNOLOGIES CORP runs the higher net margin — 28.4% vs 25.3%, a 3.0% gap on every dollar of revenue. On growth, DYNAVAX TECHNOLOGIES CORP posted the faster year-over-year revenue change (17.7% vs 2.2%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $32.6M). Over the past eight quarters, DYNAVAX TECHNOLOGIES CORP's revenue compounded faster (30.6% CAGR vs 4.9%).
Dynavax Technologies Corp is a commercial-stage biopharmaceutical company specializing in the research, development, and production of innovative vaccines and immunotherapies for infectious diseases. Its lead approved product is Heplisav-B, an adult hepatitis B vaccine, with core markets in North America and Europe, alongside a pipeline of candidates addressing unmet public health needs.
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
DVAX vs PRK — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $94.9M | $168.3M |
| Net Profit | $26.9M | $42.6M |
| Gross Margin | — | — |
| Operating Margin | 22.4% | — |
| Net Margin | 28.4% | 25.3% |
| Revenue YoY | 17.7% | 2.2% |
| Net Profit YoY | 53.0% | 10.4% |
| EPS (diluted) | $0.21 | $2.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $168.3M | ||
| Q3 25 | $94.9M | $169.5M | ||
| Q2 25 | $95.4M | $168.7M | ||
| Q1 25 | $68.2M | $157.9M | ||
| Q4 24 | $72.0M | $164.7M | ||
| Q3 24 | $80.6M | $170.3M | ||
| Q2 24 | $73.8M | $157.7M | ||
| Q1 24 | $50.8M | $152.8M |
| Q4 25 | — | $42.6M | ||
| Q3 25 | $26.9M | $47.2M | ||
| Q2 25 | $18.7M | $48.1M | ||
| Q1 25 | $-96.1M | $42.2M | ||
| Q4 24 | $7.0M | $38.6M | ||
| Q3 24 | $17.6M | $38.2M | ||
| Q2 24 | $11.4M | $39.4M | ||
| Q1 24 | $-8.7M | $35.2M |
| Q4 25 | — | — | ||
| Q3 25 | 22.4% | 34.3% | ||
| Q2 25 | 15.1% | 35.2% | ||
| Q1 25 | -34.7% | 32.4% | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 12.5% | 27.4% | ||
| Q2 24 | 7.0% | 30.6% | ||
| Q1 24 | -35.0% | 27.8% |
| Q4 25 | — | 25.3% | ||
| Q3 25 | 28.4% | 27.8% | ||
| Q2 25 | 19.6% | 28.5% | ||
| Q1 25 | -141.0% | 26.7% | ||
| Q4 24 | 9.8% | 23.5% | ||
| Q3 24 | 21.8% | 22.4% | ||
| Q2 24 | 15.4% | 25.0% | ||
| Q1 24 | -17.2% | 23.0% |
| Q4 25 | — | $2.62 | ||
| Q3 25 | $0.21 | $2.92 | ||
| Q2 25 | $0.14 | $2.97 | ||
| Q1 25 | $-0.77 | $2.60 | ||
| Q4 24 | $0.07 | $2.38 | ||
| Q3 24 | $0.12 | $2.35 | ||
| Q2 24 | $0.08 | $2.42 | ||
| Q1 24 | $-0.07 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $160.2M | $233.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $534.1M | $1.4B |
| Total Assets | $946.5M | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $233.5M | ||
| Q3 25 | $160.2M | $218.9M | ||
| Q2 25 | $99.1M | $193.1M | ||
| Q1 25 | $51.7M | $237.6M | ||
| Q4 24 | $95.9M | $160.6M | ||
| Q3 24 | $119.3M | $201.7M | ||
| Q2 24 | $112.5M | $261.5M | ||
| Q1 24 | $132.0M | $306.1M |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $534.1M | $1.3B | ||
| Q2 25 | $494.2M | $1.3B | ||
| Q1 25 | $530.9M | $1.3B | ||
| Q4 24 | $596.8M | $1.2B | ||
| Q3 24 | $681.4M | $1.2B | ||
| Q2 24 | $642.8M | $1.2B | ||
| Q1 24 | $618.5M | $1.2B |
| Q4 25 | — | $9.8B | ||
| Q3 25 | $946.5M | $9.9B | ||
| Q2 25 | $918.4M | $9.9B | ||
| Q1 25 | $945.9M | $9.9B | ||
| Q4 24 | $986.3M | $9.8B | ||
| Q3 24 | $1.1B | $9.9B | ||
| Q2 24 | $1.0B | $9.9B | ||
| Q1 24 | $986.6M | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $33.8M | $198.3M |
| Free Cash FlowOCF − Capex | $32.6M | $191.9M |
| FCF MarginFCF / Revenue | 34.4% | 114.1% |
| Capex IntensityCapex / Revenue | 1.3% | 3.8% |
| Cash ConversionOCF / Net Profit | 1.26× | 4.65× |
| TTM Free Cash FlowTrailing 4 quarters | $80.5M | $328.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $198.3M | ||
| Q3 25 | $33.8M | $52.6M | ||
| Q2 25 | $23.4M | $49.7M | ||
| Q1 25 | $-19.6M | $37.9M | ||
| Q4 24 | $53.0M | $178.8M | ||
| Q3 24 | $19.5M | $43.8M | ||
| Q2 24 | $10.7M | $50.9M | ||
| Q1 24 | $-16.7M | $35.0M |
| Q4 25 | — | $191.9M | ||
| Q3 25 | $32.6M | $51.1M | ||
| Q2 25 | $22.0M | $48.4M | ||
| Q1 25 | $-23.6M | $36.8M | ||
| Q4 24 | $49.5M | $169.7M | ||
| Q3 24 | $18.1M | $41.7M | ||
| Q2 24 | $9.9M | $49.0M | ||
| Q1 24 | $-17.4M | $31.9M |
| Q4 25 | — | 114.1% | ||
| Q3 25 | 34.4% | 30.1% | ||
| Q2 25 | 23.0% | 28.7% | ||
| Q1 25 | -34.6% | 23.3% | ||
| Q4 24 | 68.8% | 103.0% | ||
| Q3 24 | 22.5% | 24.5% | ||
| Q2 24 | 13.5% | 31.1% | ||
| Q1 24 | -34.3% | 20.8% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | 1.3% | 0.9% | ||
| Q2 25 | 1.5% | 0.8% | ||
| Q1 25 | 5.8% | 0.7% | ||
| Q4 24 | 4.8% | 5.6% | ||
| Q3 24 | 1.7% | 1.2% | ||
| Q2 24 | 1.1% | 1.2% | ||
| Q1 24 | 1.5% | 2.1% |
| Q4 25 | — | 4.65× | ||
| Q3 25 | 1.26× | 1.11× | ||
| Q2 25 | 1.25× | 1.03× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | 7.52× | 4.63× | ||
| Q3 24 | 1.11× | 1.14× | ||
| Q2 24 | 0.94× | 1.29× | ||
| Q1 24 | — | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
PRK
Segment breakdown not available.
